Stay updated on Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page
- CheckyesterdayChange DetectedA new Revision: v3.5.4 tag has been added to the page, indicating a version update. The related topics entries, including Head and neck squamous cell carcinoma and MedlinePlus Genetics, were removed from the page's related topics area.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site display or release change without altering the study content.SummaryDifference0.0%

- Check29 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.0%

- Check58 days agoChange DetectedAdded revision note v3.5.0 and removed revision note v3.4.3. The change does not modify the study details or page content.SummaryDifference0.0%

- Check65 days agoChange DetectedAdded the 'Results Submitted' status and updated the page revision to v3.4.3, replacing the previous 'No Results Posted' status and v3.4.2.SummaryDifference0.1%

- Check79 days agoChange DetectedThe institution name was updated from Sidney Kimmel Cancer Center at Thomas Jefferson University to Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.SummaryDifference0.0%

Stay in the know with updates to Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page.